Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 262 articles:
HTML format
Text format



Single Articles


    January 2017
  1. GAVIDIA-BOVADILLA G, Kanaan-Izquierdo S, Mataro-Serrat M, Perera-Lluna A, et al
    Early Prediction of Alzheimer's Disease Using Null Longitudinal Model-Based Classifiers.
    PLoS One. 2017;12:e0168011.
    PubMed     Text format     Abstract available


  2. PAPAZOGLOU A, Soos J, Lundt A, Wormuth C, et al
    Motor Cortex Theta and Gamma Architecture in Young Adult APPswePS1dE9 Alzheimer Mice.
    PLoS One. 2017;12:e0169654.
    PubMed     Text format     Abstract available


  3. SONG Y, Kim HD, Lee MK, Hong IH, et al
    Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
    PLoS One. 2017;12:e0169509.
    PubMed     Text format     Abstract available


  4. LI Y, Li Y, Li X, Zhang S, et al
    Head Injury as a Risk Factor for Dementia and Alzheimer's Disease: A Systematic Review and Meta-Analysis of 32 Observational Studies.
    PLoS One. 2017;12:e0169650.
    PubMed     Text format     Abstract available


  5. PAN X, Sang S, Fei G, Jin L, et al
    Enhanced Activities of Blood Thiamine Diphosphatase and Monophosphatase in Alzheimer's Disease.
    PLoS One. 2017;12:e0167273.
    PubMed     Text format     Abstract available


  6. MELLOTT TJ, Huleatt OM, Shade BN, Pender SM, et al
    Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice.
    PLoS One. 2017;12:e0170450.
    PubMed     Text format     Abstract available


  7. CAI K, Xu H, Guan H, Zhu W, et al
    Identification of Early-Stage Alzheimer's Disease Using Sulcal Morphology and Other Common Neuroimaging Indices.
    PLoS One. 2017;12:e0170875.
    PubMed     Text format     Abstract available


  8. KASTANENKA KV, Hou SS, Shakerdge N, Logan R, et al
    Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer's Disease.
    PLoS One. 2017;12:e0170275.
    PubMed     Text format     Abstract available


  9. MORIMOTO S, Takao M, Hatsuta H, Nishina Y, et al
    Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study.
    PLoS One. 2017;12:e0171524.
    PubMed     Text format     Abstract available


  10. MIN LJ, Kobayashi Y, Mogi M, Tsukuda K, et al
    Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice.
    PLoS One. 2017;12:e0171515.
    PubMed     Text format     Abstract available


  11. COVA I, Pomati S, Maggiore L, Forcella M, et al
    Nutritional status and body composition by bioelectrical impedance vector analysis: A cross sectional study in mild cognitive impairment and Alzheimer's disease.
    PLoS One. 2017;12:e0171331.
    PubMed     Text format     Abstract available


  12. MORRIS JK, Vidoni ED, Johnson DK, Van Sciver A, et al
    Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial.
    PLoS One. 2017;12:e0170547.
    PubMed     Text format     Abstract available


  13. XU W, Liu J, Ma D, Yuan G, et al
    Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats.
    PLoS One. 2017;12:e0172477.
    PubMed     Text format     Abstract available


  14. SCHMIDT SA, Ording AG, Horvath-Puho E, Sorensen HT, et al
    Non-melanoma skin cancer and risk of Alzheimer's disease and all-cause dementia.
    PLoS One. 2017;12:e0171527.
    PubMed     Text format     Abstract available


  15. OGAMA N, Sakurai T, Nakai T, Niida S, et al
    Impact of frontal white matter hyperintensity on instrumental activities of daily living in elderly women with Alzheimer disease and amnestic mild cognitive impairment.
    PLoS One. 2017;12:e0172484.
    PubMed     Text format     Abstract available


  16. JI H, Wang Y, Liu G, Chang L, et al
    Elevated OPRD1 promoter methylation in Alzheimer's disease patients.
    PLoS One. 2017;12:e0172335.
    PubMed     Text format     Abstract available


  17. TOLPPANEN AM, Voutilainen A, Taipale H, Tanskanen A, et al
    Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011.
    PLoS One. 2017;12:e0173450.
    PubMed     Text format     Abstract available


  18. LONG X, Chen L, Jiang C, Zhang L, et al
    Prediction and classification of Alzheimer disease based on quantification of MRI deformation.
    PLoS One. 2017;12:e0173372.
    PubMed     Text format     Abstract available


  19. HOY AR, Ly M, Carlsson CM, Okonkwo OC, et al
    Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging.
    PLoS One. 2017;12:e0173982.
    PubMed     Text format     Abstract available


  20. MELLOTT TJ, Huleatt OM, Shade BN, Pender SM, et al
    Correction: Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice.
    PLoS One. 2017;12:e0174875.
    PubMed     Text format     Abstract available


  21. SON SJ, Kim J, Park H
    Structural and functional connectional fingerprints in mild cognitive impairment and Alzheimer's disease patients.
    PLoS One. 2017;12:e0173426.
    PubMed     Text format     Abstract available


    January 2016
  22. KOBAYASHI N, Shinagawa S, Nagata T, Shimada K, et al
    Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer's Disease and Amnesic Mild Cognitive Impairment.
    PLoS One. 2016;11:e0146449.
    PubMed     Text format     Abstract available


  23. WEISSOVA K, Bartos A, Sladek M, Novakova M, et al
    Moderate Changes in the Circadian System of Alzheimer's Disease Patients Detected in Their Home Environment.
    PLoS One. 2016;11:e0146200.
    PubMed     Text format     Abstract available


  24. CHANDRASEKARAN S, Bonchev D
    Network Topology Analysis of Post-Mortem Brain Microarrays Identifies More Alzheimer's Related Genes and MicroRNAs and Points to Novel Routes for Fighting with the Disease.
    PLoS One. 2016;11:e0144052.
    PubMed     Text format     Abstract available


  25. STEVENSON JW, Conaty EA, Walsh RB, Poidomani PJ, et al
    The Amyloid Precursor Protein of Alzheimer's Disease Clusters at the Organelle/Microtubule Interface on Organelles that Bind Microtubules in an ATP Dependent Manner.
    PLoS One. 2016;11:e0147808.
    PubMed     Text format     Abstract available


  26. BERLYAND Y, Weintraub D, Xie SX, Mellis IA, et al
    An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia.
    PLoS One. 2016;11:e0147319.
    PubMed     Text format     Abstract available


  27. HANE FT, Hayes R, Lee BY, Leonenko Z, et al
    Effect of Copper and Zinc on the Single Molecule Self-Affinity of Alzheimer's Amyloid-beta Peptides.
    PLoS One. 2016;11:e0147488.
    PubMed     Text format     Abstract available


  28. MIZUNO S, Ogishima S, Kitatani K, Kikuchi M, et al
    Network Analysis of a Comprehensive Knowledge Repository Reveals a Dual Role for Ceramide in Alzheimer's Disease.
    PLoS One. 2016;11:e0148431.
    PubMed     Text format     Abstract available


  29. CHANG YT, Huang CW, Chen NC, Lin KJ, et al
    Prefrontal Lobe Brain Reserve Capacity with Resistance to Higher Global Amyloid Load and White Matter Hyperintensity Burden in Mild Stage Alzheimer's Disease.
    PLoS One. 2016;11:e0149056.
    PubMed     Text format     Abstract available


  30. SMITS FM, Porcaro C, Cottone C, Cancelli A, et al
    Electroencephalographic Fractal Dimension in Healthy Ageing and Alzheimer's Disease.
    PLoS One. 2016;11:e0149587.
    PubMed     Text format     Abstract available


  31. KOROLEV IO, Symonds LL, Bozoki AC
    Predicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic Pattern Classification.
    PLoS One. 2016;11:e0138866.
    PubMed     Text format     Abstract available


  32. LIN IC, Wang YH, Wang TJ, Wang IJ, et al
    Correction: Glaucoma, Alzheimer's Disease, and Parkinson's Disease: An 8-Year Population-Based Follow-Up Study.
    PLoS One. 2016;11:e0150789.
    PubMed     Text format     Abstract available


  33. KARCH CM, Ezerskiy LA, Bertelsen S, Goate AM, et al
    Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.
    PLoS One. 2016;11:e0148717.
    PubMed     Text format     Abstract available


  34. FONSECA MI, Chu S, Pierce AL, Brubaker WD, et al
    Analysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function.
    PLoS One. 2016;11:e0149792.
    PubMed     Text format     Abstract available


  35. PIERSMA D, Fuermaier AB, de Waard D, Davidse RJ, et al
    Prediction of Fitness to Drive in Patients with Alzheimer's Dementia.
    PLoS One. 2016;11:e0149566.
    PubMed     Text format     Abstract available


  36. IDE M, Harris M, Stevens A, Sussams R, et al
    Periodontitis and Cognitive Decline in Alzheimer's Disease.
    PLoS One. 2016;11:e0151081.
    PubMed     Text format     Abstract available



  37. Correction: Network Topology Analysis of Post-Mortem Brain Microarrays Identifies More Alzheimer's Related Genes and MicroRNAs and Points to Novel Routes for Fighting with the Disease.
    PLoS One. 2016;11:e0151122.
    PubMed     Text format     Abstract available


  38. KHOONSARI PE, Haggmark A, Lonnberg M, Mikus M, et al
    Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease.
    PLoS One. 2016;11:e0150672.
    PubMed     Text format     Abstract available


  39. WANG L, Guo L, Lu L, Sun H, et al
    Synaptosomal Mitochondrial Dysfunction in 5xFAD Mouse Model of Alzheimer's Disease.
    PLoS One. 2016;11:e0150441.
    PubMed     Text format     Abstract available


  40. MENG G, Zhong X, Mei H
    A Systematic Investigation into Aging Related Genes in Brain and Their Relationship with Alzheimer's Disease.
    PLoS One. 2016;11:e0150624.
    PubMed     Text format     Abstract available


  41. YIN Y, Liu Y, Pan X, Chen R, et al
    Interleukin-1beta Promoter Polymorphism Enhances the Risk of Sleep Disturbance in Alzheimer's Disease.
    PLoS One. 2016;11:e0149945.
    PubMed     Text format     Abstract available


  42. COVA I, Clerici F, Rossi A, Cucumo V, et al
    Weight Loss Predicts Progression of Mild Cognitive Impairment to Alzheimer's Disease.
    PLoS One. 2016;11:e0151710.
    PubMed     Text format     Abstract available


  43. FRANCOIS A, Julian A, Ragot S, Dugast E, et al
    Correction: Inflammatory Stress on Autophagy in Peripheral Blood Mononuclear Cells from Patients with Alzheimer's Disease during 24 Months of Follow-Up.
    PLoS One. 2016;11:e0143933.
    PubMed     Text format     Abstract available


  44. WANG S, Yu L, Yang H, Li C, et al
    Oridonin Attenuates Synaptic Loss and Cognitive Deficits in an Abeta1-42-Induced Mouse Model of Alzheimer's Disease.
    PLoS One. 2016;11:e0151397.
    PubMed     Text format     Abstract available


  45. SU Y, Blazey TM, Owen CJ, Christensen JJ, et al
    Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group.
    PLoS One. 2016;11:e0152082.
    PubMed     Text format     Abstract available


  46. SUNG HY, Choi BO, Jeong JH, Kong KA, et al
    Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer's Disease.
    PLoS One. 2016;11:e0153156.
    PubMed     Text format     Abstract available


  47. PUTHIYEDTH N, Riveros C, Berretta R, Moscato P, et al
    Identification of Differentially Expressed Genes through Integrated Study of Alzheimer's Disease Affected Brain Regions.
    PLoS One. 2016;11:e0152342.
    PubMed     Text format     Abstract available


  48. CHIU PY, Tsai CT, Chen PK, Chen WJ, et al
    Neuropsychiatric Symptoms in Parkinson's Disease Dementia Are More Similar to Alzheimer's Disease than Dementia with Lewy Bodies: A Case-Control Study.
    PLoS One. 2016;11:e0153989.
    PubMed     Text format     Abstract available


  49. WATTS A, Walters RW, Hoffman L, Templin J, et al
    Intra-Individual Variability of Physical Activity in Older Adults With and Without Mild Alzheimer's Disease.
    PLoS One. 2016;11:e0153898.
    PubMed     Text format     Abstract available


  50. SCHMIDT-RICHBERG A, Ledig C, Guerrero R, Molina-Abril H, et al
    Learning Biomarker Models for Progression Estimation of Alzheimer's Disease.
    PLoS One. 2016;11:e0153040.
    PubMed     Text format     Abstract available


  51. CUNHA LP, Lopes LC, Costa-Cunha LV, Costa CF, et al
    Macular Thickness Measurements with Frequency Domain-OCT for Quantification of Retinal Neural Loss and its Correlation with Cognitive Impairment in Alzheimer's Disease.
    PLoS One. 2016;11:e0153830.
    PubMed     Text format     Abstract available


  52. CRISTOFANO A, Sapere N, La Marca G, Angiolillo A, et al
    Serum Levels of Acyl-Carnitines along the Continuum from Normal to Alzheimer's Dementia.
    PLoS One. 2016;11:e0155694.
    PubMed     Text format     Abstract available


  53. PAI MC, Lee CC
    The Incidence and Recurrence of Getting Lost in Community-Dwelling People with Alzheimer's Disease: A Two and a Half-Year Follow-Up.
    PLoS One. 2016;11:e0155480.
    PubMed     Text format     Abstract available


  54. CHEN X, Zhou Y, Wang R, Cao H, et al
    Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.
    PLoS One. 2016;11:e0154406.
    PubMed     Text format     Abstract available


  55. OSTROWSKI PP, Barszczyk A, Forstenpointner J, Zheng W, et al
    Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease.
    PLoS One. 2016;11:e0155733.
    PubMed     Text format     Abstract available


  56. LEE NK, Yang J, Chang EH, Park SE, et al
    Intra-Arterially Delivered Mesenchymal Stem Cells Are Not Detected in the Brain Parenchyma in an Alzheimer's Disease Mouse Model.
    PLoS One. 2016;11:e0155912.
    PubMed     Text format     Abstract available


  57. SASSI C, Ridge PG, Nalls MA, Gibbs R, et al
    Influence of Coding Variability in APP-Abeta Metabolism Genes in Sporadic Alzheimer's Disease.
    PLoS One. 2016;11:e0150079.
    PubMed     Text format     Abstract available


  58. CHEN Y, Liu C, Parker WD, Chen H, et al
    Mitochondrial DNA Rearrangement Spectrum in Brain Tissue of Alzheimer's Disease: Analysis of 13 Cases.
    PLoS One. 2016;11:e0154582.
    PubMed     Text format     Abstract available


  59. KOYAMA A, Hashimoto M, Tanaka H, Fujise N, et al
    Malnutrition in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Lobar Degeneration: Comparison Using Serum Albumin, Total Protein, and Hemoglobin Level.
    PLoS One. 2016;11:e0157053.
    PubMed     Text format     Abstract available


  60. KALLO G, Emri M, Varga Z, Ujhelyi B, et al
    Changes in the Chemical Barrier Composition of Tears in Alzheimer's Disease Reveal Potential Tear Diagnostic Biomarkers.
    PLoS One. 2016;11:e0158000.
    PubMed     Text format     Abstract available


  61. LOCKHART SN, Baker SL, Okamura N, Furukawa K, et al
    Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351.
    PLoS One. 2016;11:e0158460.
    PubMed     Text format     Abstract available


  62. VENTURELLI M, Ce E, Limonta E, Muti E, et al
    Possible Predictors of Involuntary Weight Loss in Patients with Alzheimer's Disease.
    PLoS One. 2016;11:e0157384.
    PubMed     Text format     Abstract available


  63. YUAN H, Xia Q, Ling K, Wang X, et al
    Association of Choline Acetyltransferase Gene Polymorphisms (SNPs rs868750G/A, rs1880676G/A, rs2177369G/A and rs3810950G/A) with Alzheimer's Disease Risk: A Meta-Analysis.
    PLoS One. 2016;11:e0159022.
    PubMed     Text format     Abstract available


  64. YAGI-UTSUMI M, Kato K, Nishimura K
    Membrane-Induced Dichotomous Conformation of Amyloid beta with the Disordered N-Terminal Segment Followed by the Stable C-Terminal beta Structure.
    PLoS One. 2016;11:e0146405.
    PubMed     Text format     Abstract available


  65. LOWE LC, Gaser C, Franke K
    The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    PLoS One. 2016;11:e0157514.
    PubMed     Text format     Abstract available


  66. CHEN CH, Lin CL, Kao CH
    Irritable Bowel Syndrome Is Associated with an Increased Risk of Dementia: A Nationwide Population-Based Study.
    PLoS One. 2016;11:e0144589.
    PubMed     Text format     Abstract available


  67. HANSEN HH, Fabricius K, Barkholt P, Kongsbak-Wismann P, et al
    Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on beta-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    PLoS One. 2016;11:e0158205.
    PubMed     Text format     Abstract available


  68. LUTSEY PL, Norby FL, Gottesman RF, Mosley T, et al
    Sleep Apnea, Sleep Duration and Brain MRI Markers of Cerebral Vascular Disease and Alzheimer's Disease: The Atherosclerosis Risk in Communities Study (ARIC).
    PLoS One. 2016;11:e0158758.
    PubMed     Text format     Abstract available


  69. GHOSAL K, Fan Q, Dawson HN, Pimplikar SW, et al
    Tau Protein Mediates APP Intracellular Domain (AICD)-Induced Alzheimer's-Like Pathological Features in Mice.
    PLoS One. 2016;11:e0159435.
    PubMed     Text format     Abstract available


  70. SHEKHAR S, Kumar R, Rai N, Kumar V, et al
    Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer's Disease and Mild Cognitive Impairment Patients.
    PLoS One. 2016;11:e0159099.
    PubMed     Text format     Abstract available


  71. LI X, Cui J, Yu Y, Li W, et al
    Traditional Chinese Nootropic Medicine Radix Polygalae and Its Active Constituent Onjisaponin B Reduce beta-Amyloid Production and Improve Cognitive Impairments.
    PLoS One. 2016;11:e0151147.
    PubMed     Text format     Abstract available


  72. MAKANI V, Jang YG, Christopher K, Judy W, et al
    BBB-Permeable, Neuroprotective, and Neurotrophic Polysaccharide, Midi-GAGR.
    PLoS One. 2016;11:e0149715.
    PubMed     Text format     Abstract available


  73. HOARAU M, Malbert Y, Irague R, Hureau C, et al
    A Robust and Efficient Production and Purification Procedure of Recombinant Alzheimers Disease Methionine-Modified Amyloid-beta Peptides.
    PLoS One. 2016;11:e0161209.
    PubMed     Text format     Abstract available


  74. LI B, Shi J, Gutman BA, Baxter LC, et al
    Influence of APOE Genotype on Hippocampal Atrophy over Time - An N=1925 Surface-Based ADNI Study.
    PLoS One. 2016;11:e0152901.
    PubMed     Text format     Abstract available


  75. CHOI SH, Park SJ, Kim NR
    Macular Ganglion Cell -Inner Plexiform Layer Thickness Is Associated with Clinical Progression in Mild Cognitive Impairment and Alzheimers Disease.
    PLoS One. 2016;11:e0162202.
    PubMed     Text format     Abstract available


  76. OREMUS M, Xie F, Gaebel K
    Development of Clinical Vignettes to Describe Alzheimer's Disease Health States: A Qualitative Study.
    PLoS One. 2016;11:e0162422.
    PubMed     Text format     Abstract available


  77. LIANG FW, Chan W, Chen PJ, Zimmerman C, et al
    Cognitively-Related Basic Activities of Daily Living Impairment Greatly Increases the Risk of Death in Alzheimers Disease.
    PLoS One. 2016;11:e0160671.
    PubMed     Text format     Abstract available


  78. ROSENTHAL J, Belfort G, Isaacson D
    Early Treatment Critical: Bexarotene Reduces Amyloid-Beta Burden In Silico.
    PLoS One. 2016;11:e0153150.
    PubMed     Text format     Abstract available


  79. RAJA WK, Mungenast AE, Lin YT, Ko T, et al
    Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes.
    PLoS One. 2016;11:e0161969.
    PubMed     Text format     Abstract available


  80. CHEN PT, Chen CL, Lin LT, Lo CH, et al
    Design of Peptide Substrate for Sensitively and Specifically Detecting Two Abeta-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme.
    PLoS One. 2016;11:e0153360.
    PubMed     Text format     Abstract available


  81. SU Y, Blazey TM, Owen CJ, Christensen JJ, et al
    Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group.
    PLoS One. 2016;11:e0163669.
    PubMed     Text format     Abstract available


  82. LEE HK, Velazquez Sanchez C, Chen M, Morin PJ, et al
    Three Dimensional Human Neuro-Spheroid Model of Alzheimer's Disease Based on Differentiated Induced Pluripotent Stem Cells.
    PLoS One. 2016;11:e0163072.
    PubMed     Text format     Abstract available


  83. BAEK MJ, Kim K, Park YH, Kim S, et al
    The Validity and Reliability of the Mini-Mental State Examination-2 for Detecting Mild Cognitive Impairment and Alzheimer's Disease in a Korean Population.
    PLoS One. 2016;11:e0163792.
    PubMed     Text format     Abstract available


  84. CORREA MS, Giacobbo BL, Vedovelli K, Lima DB, et al
    Age Effects on Cognitive and Physiological Parameters in Familial Caregivers of Alzheimer's Disease Patients.
    PLoS One. 2016;11:e0162619.
    PubMed     Text format     Abstract available


  85. SASAOKA S, Matsui T, Hane Y, Abe J, et al
    Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events.
    PLoS One. 2016;11:e0164309.
    PubMed     Text format     Abstract available


  86. MORRONE CD, Thomason LA, Brown ME, Aubert I, et al
    Effects of Neurotrophic Support and Amyloid-Targeted Combined Therapy on Adult Hippocampal Neurogenesis in a Transgenic Model of Alzheimer's Disease.
    PLoS One. 2016;11:e0165393.
    PubMed     Text format     Abstract available


  87. VISHNU VY, Modi M, Sharma S, Mohanty M, et al
    Role of Plasma Clusterin in Alzheimer's Disease-A Pilot Study in a Tertiary Hospital in Northern India.
    PLoS One. 2016;11:e0166369.
    PubMed     Text format     Abstract available


  88. CERMAK S, Kosicek M, Mladenovic-Djordjevic A, Smiljanic K, et al
    Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins.
    PLoS One. 2016;11:e0167428.
    PubMed     Text format     Abstract available


  89. DAMMERS C, Yolcu D, Kukuk L, Willbold D, et al
    Selection and Characterization of Tau Binding -Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease.
    PLoS One. 2016;11:e0167432.
    PubMed     Text format     Abstract available


  90. ZHANG M, Schmitt-Ulms G, Sato C, Xi Z, et al
    Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
    PLoS One. 2016;11:e0168812.
    PubMed     Text format     Abstract available


  91. KAO LT, Kang JH, Lin HC, Huang CC, et al
    Rheumatoid Arthritis Was Negatively Associated with Alzheimer's Disease: A Population-Based Case-Control Study.
    PLoS One. 2016;11:e0168106.
    PubMed     Text format     Abstract available


  92. STUDNICKI M, Wozniak G, Stepkowski D
    The Calculator of Anti-Alzheimer's Diet. Macronutrients.
    PLoS One. 2016;11:e0168385.
    PubMed     Text format     Abstract available


  93. KOBAYASHI N, Shinagawa S, Nagata T, Shimada K, et al
    Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    PLoS One. 2016;11:e0168816.
    PubMed     Text format     Abstract available


  94. PEREZ C, Ziburkus J, Ullah G
    Analyzing and Modeling the Dysfunction of Inhibitory Neurons in Alzheimer's Disease.
    PLoS One. 2016;11:e0168800.
    PubMed     Text format     Abstract available


  95. KRUSE N, Schlossmacher MG, Schulz-Schaeffer WJ, Vanmechelen E, et al
    A First Tetraplex Assay for the Simultaneous Quantification of Total alpha-Synuclein, Tau, beta-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid.
    PLoS One. 2016;11:e0153564.
    PubMed     Text format     Abstract available


    January 2015
  96. MANDLER M, Santic R, Gruber P, Cinar Y, et al
    Tailoring the antibody response to aggregated ass using novel Alzheimer-vaccines.
    PLoS One. 2015;10:e0115237.
    PubMed     Text format     Abstract available


  97. YATES SC, Zafar A, Rabai EM, Foxall JB, et al
    The Effects of Two Polymorphisms on p21cip1 Function and Their Association with Alzheimer's Disease in a Population of European Descent.
    PLoS One. 2015;10:e0114050.
    PubMed     Text format     Abstract available


  98. CHEN JH, Ke KF, Lu JH, Qiu YH, et al
    Protection of TGF-beta1 against Neuroinflammation and Neurodegeneration in Abeta1-42-Induced Alzheimer's Disease Model Rats.
    PLoS One. 2015;10:e0116549.
    PubMed     Text format     Abstract available


  99. D'AOUST LN, Cummings AC, Laux R, Fuzzell D, et al
    Examination of candidate exonic variants for association to Alzheimer disease in the amish.
    PLoS One. 2015;10:e0118043.
    PubMed     Text format     Abstract available


  100. GILMARTIN JF, Vaatainen S, Tormalehto S, Bell JS, et al
    Depressive Symptoms Are Associated with Analgesic Use in People with Alzheimer's Disease: Kuopio ALSOVA Study.
    PLoS One. 2015;10:e0117926.
    PubMed     Text format     Abstract available


  101. GROTZ C, Letenneur L, Bonsang E, Amieva H, et al
    Retirement Age and the Age of Onset of Alzheimer's Disease: Results from the ICTUS Study.
    PLoS One. 2015;10:e0115056.
    PubMed     Text format     Abstract available


  102. LAU HC, Lee IK, Ko PW, Lee HW, et al
    Non-Invasive Screening for Alzheimer's Disease by Sensing Salivary Sugar Using Drosophila Cells Expressing Gustatory Receptor (Gr5a) Immobilized on an Extended Gate Ion-Sensitive Field-Effect Transistor (EG-ISFET) Biosensor.
    PLoS One. 2015;10:e0117810.
    PubMed     Text format     Abstract available


  103. YU TS, Kim A, Kernie SG
    Donepezil Rescues Spatial Learning and Memory Deficits following Traumatic Brain Injury Independent of Its Effects on Neurogenesis.
    PLoS One. 2015;10:e0118793.
    PubMed     Text format     Abstract available


  104. MO JA, Lim JH, Sul AR, Lee M, et al
    Cerebrospinal Fluid beta-Amyloid1-42 Levels in the Differential Diagnosis of Alzheimer's Disease-Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0116802.
    PubMed     Text format     Abstract available


  105. BISHNOI RJ, Palmer RF, Royall DR
    Serum Interleukin (IL)-15 as a Biomarker of Alzheimer's Disease.
    PLoS One. 2015;10:e0117282.
    PubMed     Text format     Abstract available


  106. ANO Y, Ozawa M, Kutsukake T, Sugiyama S, et al
    Preventive Effects of a Fermented Dairy Product against Alzheimer's Disease and Identification of a Novel Oleamide with Enhanced Microglial Phagocytosis and Anti-Inflammatory Activity.
    PLoS One. 2015;10:e0118512.
    PubMed     Text format     Abstract available


  107. ANDREASEN N, Simeoni M, Ostlund H, Lisjo PI, et al
    First Administration of the Fc-Attenuated Anti-beta Amyloid Antibody GSK933776 to Patients with Mild Alzheimer's Disease: A Randomized, Placebo-Controlled Study.
    PLoS One. 2015;10:e0098153.
    PubMed     Text format     Abstract available


  108. JAYASENA T, Poljak A, Braidy N, Smythe G, et al
    Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma.
    PLoS One. 2015;10:e0116092.
    PubMed     Text format     Abstract available


  109. AUBRY S, Shin W, Crary JF, Lefort R, et al
    Assembly and interrogation of Alzheimer's disease genetic networks reveal novel regulators of progression.
    PLoS One. 2015;10:e0120352.
    PubMed     Text format     Abstract available


  110. LIU-SEIFERT H, Andersen SW, Lipkovich I, Holdridge KC, et al
    A novel approach to delayed-start analyses for demonstrating disease-modifying effects in Alzheimer's disease.
    PLoS One. 2015;10:e0119632.
    PubMed     Text format     Abstract available


  111. OUYANG X, Chen K, Yao L, Wu X, et al
    Independent component analysis-based identification of covariance patterns of microstructural white matter damage in Alzheimer's disease.
    PLoS One. 2015;10:e0119714.
    PubMed     Text format     Abstract available


  112. BEZZINA C, Verret L, Juan C, Remaud J, et al
    Early onset of hypersynchronous network activity and expression of a marker of chronic seizures in the tg2576 mouse model of Alzheimer's disease.
    PLoS One. 2015;10:e0119910.
    PubMed     Text format     Abstract available



  113. Correction: Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer's Disease.
    PLoS One. 2015;10:e0121509.
    PubMed     Text format     Abstract available


  114. ESSA MM, Subash S, Akbar M, Al-Adawi S, et al
    Long-term dietary supplementation of pomegranates, figs and dates alleviate neuroinflammation in a transgenic mouse model of Alzheimer's disease.
    PLoS One. 2015;10:e0120964.
    PubMed     Text format     Abstract available


  115. GRAHAM SF, Chevallier OP, Elliott CT, Holscher C, et al
    Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and L-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer's disease.
    PLoS One. 2015;10:e0119452.
    PubMed     Text format     Abstract available


  116. HERRMANN L, Wiegmann C, Arsalan-Werner A, Hilbrich I, et al
    Hook proteins: association with Alzheimer pathology and regulatory role of hook3 in amyloid Beta generation.
    PLoS One. 2015;10:e0119423.
    PubMed     Text format     Abstract available


  117. OIKAWA N, Matsubara T, Fukuda R, Yasumori H, et al
    Imbalance in Fatty-Acid-chain length of gangliosides triggers Alzheimer amyloid deposition in the precuneus.
    PLoS One. 2015;10:e0121356.
    PubMed     Text format     Abstract available


  118. HOHSFIELD LA, Humpel C
    Intravenous Infusion of Monocytes Isolated from 2-Week-Old Mice Enhances Clearance of Beta-Amyloid Plaques in an Alzheimer Mouse Model.
    PLoS One. 2015;10:e0121930.
    PubMed     Text format     Abstract available


  119. KWON H, Crisostomo AC, Smalls HM, Finke JM, et al
    Anti-abeta oligomer IgG and surface sialic Acid in intravenous immunoglobulin: measurement and correlation with clinical outcomes in Alzheimer's disease treatment.
    PLoS One. 2015;10:e0120420.
    PubMed     Text format     Abstract available


  120. LEE CN, Ko D, Suh YW, Park KW, et al
    Cognitive functions and stereopsis in patients with Parkinson's disease and Alzheimer's disease using 3-dimensional television: a case controlled trial.
    PLoS One. 2015;10:e0123229.
    PubMed     Text format     Abstract available


  121. ZHANG L, Fang Y, Lian Y, Chen Y, et al
    Brain-derived neurotrophic factor ameliorates learning deficits in a rat model of Alzheimer's disease induced by abeta1-42.
    PLoS One. 2015;10:e0122415.
    PubMed     Text format     Abstract available


  122. HOLTHOFF VA, Marschner K, Scharf M, Steding J, et al
    Effects of Physical Activity Training in Patients with Alzheimer's Dementia: Results of a Pilot RCT Study.
    PLoS One. 2015;10:e0121478.
    PubMed     Text format     Abstract available


  123. FRIEDMAN EJ, Young K, Tremper G, Liang J, et al
    Directed Network Motifs in Alzheimer's Disease and Mild Cognitive Impairment.
    PLoS One. 2015;10:e0124453.
    PubMed     Text format     Abstract available


  124. MATSUNAGA S, Kishi T, Iwata N
    Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis.
    PLoS One. 2015;10:e0123289.
    PubMed     Text format     Abstract available


  125. YU Z, Li W, Hou D, Zhou L, et al
    Relationship between Adiponectin Gene Polymorphisms and Late-Onset Alzheimer's Disease.
    PLoS One. 2015;10:e0125186.
    PubMed     Text format     Abstract available


  126. WILCOX KC, Marunde MR, Das A, Velasco PT, et al
    Nanoscale Synaptic Membrane Mimetic Allows Unbiased High Throughput Screen That Targets Binding Sites for Alzheimer's-Associated Abeta Oligomers.
    PLoS One. 2015;10:e0125263.
    PubMed     Text format     Abstract available


  127. DEWJI NN, Singer SJ, Masliah E, Rockenstein E, et al
    Peptides of Presenilin-1 Bind the Amyloid Precursor Protein Ectodomain and Offer a Novel and Specific Therapeutic Approach to Reduce ss-Amyloid in Alzheimer's Disease.
    PLoS One. 2015;10:e0122451.
    PubMed     Text format     Abstract available


  128. SUZUKI Y, Nakamura Y, Yamada K, Igarashi H, et al
    Reduced CSF Water Influx in Alzheimer's Disease Supporting the beta-Amyloid Clearance Hypothesis.
    PLoS One. 2015;10:e0123708.
    PubMed     Text format     Abstract available


  129. LIU P, Paulson JB, Forster CL, Shapiro SL, et al
    Characterization of a Novel Mouse Model of Alzheimer's Disease-Amyloid Pathology and Unique beta-Amyloid Oligomer Profile.
    PLoS One. 2015;10:e0126317.
    PubMed     Text format     Abstract available


  130. FONTEH AN, Ormseth C, Chiang J, Cipolla M, et al
    Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's disease.
    PLoS One. 2015;10:e0125597.
    PubMed     Text format     Abstract available


  131. WANG Z, Wang J, Zhang H, Mchugh R, et al
    Interhemispheric Functional and Structural Disconnection in Alzheimer's Disease: A Combined Resting-State fMRI and DTI Study.
    PLoS One. 2015;10:e0126310.
    PubMed     Text format     Abstract available


  132. JACKSON HM, Onos KD, Pepper KW, Graham LC, et al
    DBA/2J genetic background exacerbates spontaneous lethal seizures but lessens amyloid deposition in a mouse model of Alzheimer's disease.
    PLoS One. 2015;10:e0125897.
    PubMed     Text format     Abstract available


  133. LEINONEN A, Koponen M, Hartikainen S
    Systematic Review: Representativeness of Participants in RCTs of Acetylcholinesterase Inhibitors.
    PLoS One. 2015;10:e0124500.
    PubMed     Text format     Abstract available


  134. TORSO M, Serra L, Giulietti G, Spano B, et al
    Strategic lesions in the anterior thalamic radiation and apathy in early Alzheimer's disease.
    PLoS One. 2015;10:e0124998.
    PubMed     Text format     Abstract available


  135. STEPKOWSKI D, Wozniak G, Studnicki M
    Correlation of Alzheimer's disease death rates with historical per capita personal income in the USA.
    PLoS One. 2015;10:e0126139.
    PubMed     Text format     Abstract available


  136. BHATT DP, Puig KL, Gorr MW, Wold LE, et al
    A pilot study to assess effects of long-term inhalation of airborne particulate matter on early Alzheimer-like changes in the mouse brain.
    PLoS One. 2015;10:e0127102.
    PubMed     Text format     Abstract available


  137. DENK J, Boelmans K, Siegismund C, Lassner D, et al
    MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
    PLoS One. 2015;10:e0126423.
    PubMed     Text format     Abstract available


  138. LIU X, Zuo H, Wang D, Peng R, et al
    Improvement of spatial memory disorder and hippocampal damage by exposure to electromagnetic fields in an Alzheimer's disease rat model.
    PLoS One. 2015;10:e0126963.
    PubMed     Text format     Abstract available


  139. VERMA M, Beaulieu-Abdelahad D, Ait-Ghezala G, Li R, et al
    Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD.
    PLoS One. 2015;10:e0128224.
    PubMed     Text format     Abstract available


  140. IRWIN RW, Solinsky CM, Loya CM, Salituro FG, et al
    Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease.
    PLoS One. 2015;10:e0128313.
    PubMed     Text format     Abstract available


  141. HU C, Cheng L, Sepulcre J, Johnson KA, et al
    A spectral graph regression model for learning brain connectivity of Alzheimer's disease.
    PLoS One. 2015;10:e0128136.
    PubMed     Text format     Abstract available


  142. YUN HJ, Kwak K, Lee JM
    Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism.
    PLoS One. 2015;10:e0129250.
    PubMed     Text format     Abstract available


  143. BLANC F, Colloby SJ, Philippi N, de Petigny X, et al
    Cortical Thickness in Dementia with Lewy Bodies and Alzheimer's Disease: A Comparison of Prodromal and Dementia Stages.
    PLoS One. 2015;10:e0127396.
    PubMed     Text format     Abstract available



  144. Correction: Relationship between Adiponectin Gene Polymorphisms and Late-Onset Alzheimer's Disease.
    PLoS One. 2015;10:e0130521.
    PubMed     Text format     Abstract available


  145. JIANG N, Leithold LH, Post J, Ziehm T, et al
    Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer s Disease.
    PLoS One. 2015;10:e0128553.
    PubMed     Text format     Abstract available


  146. COLBY-MILLEY J, Cavanagh C, Jego S, Breitner JC, et al
    Sleep-Wake Cycle Dysfunction in the TgCRND8 Mouse Model of Alzheimer's Disease: From Early to Advanced Pathological Stages.
    PLoS One. 2015;10:e0130177.
    PubMed     Text format     Abstract available


  147. ZHANG Y, Lin C, Zhang L, Cui Y, et al
    Cognitive Improvement during Treatment for Mild Alzheimer's Disease with a Chinese Herbal Formula: A Randomized Controlled Trial.
    PLoS One. 2015;10:e0130353.
    PubMed     Text format     Abstract available


  148. ZHAO H, Li X, Wu W, Li Z, et al
    Atrophic Patterns of the Frontal-Subcortical Circuits in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    PLoS One. 2015;10:e0130017.
    PubMed     Text format     Abstract available


  149. MODI KK, Roy A, Brahmachari S, Rangasamy SB, et al
    Cinnamon and Its Metabolite Sodium Benzoate Attenuate the Activation of p21rac and Protect Memory and Learning in an Animal Model of Alzheimer's Disease.
    PLoS One. 2015;10:e0130398.
    PubMed     Text format     Abstract available



  150. Correction: A Novel Approach to Delayed-Start Analyses for Demonstrating Disease-Modifying Effects in Alzheimer's Disease.
    PLoS One. 2015;10:e0131338.
    PubMed     Text format     Abstract available



  151. Correction: Allopregnanolone Preclinical Acute Pharmacokinetic and Pharmacodynamic Studies to Predict Tolerability and Efficacy for Alzheimer's Disease.
    PLoS One. 2015;10:e0132210.
    PubMed     Text format     Abstract available


  152. BACH JP, Gold M, Mengel D, Hattesohl A, et al
    Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease.
    PLoS One. 2015;10:e0132227.
    PubMed     Text format     Abstract available


  153. YU H, Wang X, He R, Liang R, et al
    Measuring the Caregiver Burden of Caring for Community-Residing People with Alzheimer's Disease.
    PLoS One. 2015;10:e0132168.
    PubMed     Text format     Abstract available


  154. VERMA M, Beaulieu-Abdelahad D, Ait-Ghezala G, Li R, et al
    Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD.
    PLoS One. 2015;10:e0134776.
    PubMed     Text format     Abstract available


  155. LUTZENBERGER M, Burwinkel M, Riemer C, Bode V, et al
    Ablation of CCAAT/Enhancer-Binding Protein Delta (C/EBPD): Increased Plaque Burden in a Murine Alzheimer's Disease Model.
    PLoS One. 2015;10:e0134228.
    PubMed     Text format     Abstract available


  156. WENNSTROM M, Surova Y, Hall S, Nilsson C, et al
    The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.
    PLoS One. 2015;10:e0135458.
    PubMed     Text format     Abstract available


  157. HENDRICKSON RC, Lee AY, Song Q, Liaw A, et al
    High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid.
    PLoS One. 2015;10:e0135365.
    PubMed     Text format     Abstract available


  158. DU LY, Chang LY, Ardiles AO, Tapia-Rojas C, et al
    Alzheimer's Disease-Related Protein Expression in the Retina of Octodon degus.
    PLoS One. 2015;10:e0135499.
    PubMed     Text format     Abstract available


  159. WANG XD, Lu H, Shi Z, Cai L, et al
    A Pilot Study on Clinical and Neuroimaging Characteristics of Chinese Posterior Cortical Atrophy: Comparison with Typical Alzheimer's Disease.
    PLoS One. 2015;10:e0134956.
    PubMed     Text format     Abstract available


  160. KAI K, Hashimoto M, Amano K, Tanaka H, et al
    Relationship between Eating Disturbance and Dementia Severity in Patients with Alzheimer's Disease.
    PLoS One. 2015;10:e0133666.
    PubMed     Text format     Abstract available


  161. COPPOLA G, Di Renzo A, Ziccardi L, Martelli F, et al
    Optical Coherence Tomography in Alzheimer's Disease: A Meta-Analysis.
    PLoS One. 2015;10:e0134750.
    PubMed     Text format     Abstract available


  162. YANG EJ, Ahn S, Ryu J, Choi MS, et al
    Phloroglucinol Attenuates the Cognitive Deficits of the 5XFAD Mouse Model of Alzheimer's Disease.
    PLoS One. 2015;10:e0135686.
    PubMed     Text format     Abstract available


  163. KHAN W, Aguilar C, Kiddle SJ, Doyle O, et al
    A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer's Disease.
    PLoS One. 2015;10:e0134368.
    PubMed     Text format     Abstract available


  164. MORI Y, Yoshino Y, Ochi S, Yamazaki K, et al
    TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer's Disease and Schizophrenia.
    PLoS One. 2015;10:e0136835.
    PubMed     Text format     Abstract available


  165. AMAT-UR-RASOOL H, Ahmed M
    Designing Second Generation Anti-Alzheimer Compounds as Inhibitors of Human Acetylcholinesterase: Computational Screening of Synthetic Molecules and Dietary Phytochemicals.
    PLoS One. 2015;10:e0136509.
    PubMed     Text format     Abstract available


  166. SONG WJ, Son MY, Lee HW, Seo H, et al
    Enhancement of BACE1 Activity by p25/Cdk5-Mediated Phosphorylation in Alzheimer's Disease.
    PLoS One. 2015;10:e0136950.
    PubMed     Text format     Abstract available


  167. ULLAH G, Demuro A, Parker I, Pearson JE, et al
    Analyzing and Modeling the Kinetics of Amyloid Beta Pores Associated with Alzheimer's Disease Pathology.
    PLoS One. 2015;10:e0137357.
    PubMed     Text format     Abstract available


  168. WANG W, Mandel J, Bouaziz J, Commenges D, et al
    A Multi-Marker Genetic Association Test Based on the Rasch Model Applied to Alzheimer's Disease.
    PLoS One. 2015;10:e0138223.
    PubMed     Text format     Abstract available


  169. HSU JL, Lee WJ, Liao YC, Lirng JF, et al
    Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    PLoS One. 2015;10:e0137121.
    PubMed     Text format     Abstract available


  170. CUTLER T, Sarkar A, Moran M, Steffensmeier A, et al
    Drosophila Eye Model to Study Neuroprotective Role of CREB Binding Protein (CBP) in Alzheimer's Disease.
    PLoS One. 2015;10:e0137691.
    PubMed     Text format     Abstract available


  171. BOBKOVA NV, Lyabin DN, Medvinskaya NI, Samokhin AN, et al
    The Y-Box Binding Protein 1 Suppresses Alzheimer's Disease Progression in Two Animal Models.
    PLoS One. 2015;10:e0138867.
    PubMed     Text format     Abstract available


  172. FRANCOIS A, Julian A, Ragot S, Dugast E, et al
    Inflammatory Stress on Autophagy in Peripheral Blood Mononuclear Cells from Patients with Alzheimer's Disease during 24 Months of Follow-Up.
    PLoS One. 2015;10:e0138326.
    PubMed     Text format     Abstract available


  173. LUGLI G, Cohen AM, Bennett DA, Shah RC, et al
    Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.
    PLoS One. 2015;10:e0139233.
    PubMed     Text format     Abstract available


  174. KYRTSOS CR, Baras JS
    Modeling the Role of the Glymphatic Pathway and Cerebral Blood Vessel Properties in Alzheimer's Disease Pathogenesis.
    PLoS One. 2015;10:e0139574.
    PubMed     Text format     Abstract available


  175. THAI C, Lim YY, Villemagne VL, Laws SM, et al
    Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE epsilon4 and Is Detectable over 18-Months.
    PLoS One. 2015;10:e0139082.
    PubMed     Text format     Abstract available


  176. ISHIKI A, Okamura N, Furukawa K, Furumoto S, et al
    Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography.
    PLoS One. 2015;10:e0140311.
    PubMed     Text format     Abstract available


  177. LIANG H, Shi Y, Kou Z, Peng Y, et al
    Inhibition of BACE1 Activity by a DNA Aptamer in an Alzheimer's Disease Cell Model.
    PLoS One. 2015;10:e0140733.
    PubMed     Text format     Abstract available


  178. HU J, Lin T, Gao Y, Xu J, et al
    The resveratrol trimer miyabenol C inhibits beta-secretase activity and beta-amyloid generation.
    PLoS One. 2015;10:e0115973.
    PubMed     Text format     Abstract available


  179. SIMAN R, Cocca R, Dong Y
    The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy.
    PLoS One. 2015;10:e0142340.
    PubMed     Text format     Abstract available


  180. SHANMUGANATHAN B, Sheeja Malar D, Sathya S, Pandima Devi K, et al
    Antiaggregation Potential of Padina gymnospora against the Toxic Alzheimer's Beta-Amyloid Peptide 25-35 and Cholinesterase Inhibitory Property of Its Bioactive Compounds.
    PLoS One. 2015;10:e0141708.
    PubMed     Text format     Abstract available


  181. LIU YC, Liu YY, Yip PK, Akanuma K, et al
    More Delusions May Be Observed in Low-Proficient Multilingual Alzheimer's Disease Patients.
    PLoS One. 2015;10:e0140714.
    PubMed     Text format     Abstract available


  182. GUO JP, Pan JX, Xiong L, Xia WF, et al
    Iron Chelation Inhibits Osteoclastic Differentiation In Vitro and in Tg2576 Mouse Model of Alzheimer's Disease.
    PLoS One. 2015;10:e0139395.
    PubMed     Text format     Abstract available


  183. WEISSMILLER AM, Natera-Naranjo O, Reyna SM, Pearn ML, et al
    A gamma-secretase inhibitor, but not a gamma-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP.
    PLoS One. 2015;10:e0118379.
    PubMed     Text format     Abstract available


  184. MENDEZ MF, Joshi A, Daianu M, Jimenez E, et al
    White Matter Changes Associated with Resting Sympathetic Tone in Frontotemporal Dementia vs. Alzheimer's Disease.
    PLoS One. 2015;10:e0142445.
    PubMed     Text format     Abstract available


  185. WANG S, Cu Y, Wang C, Xie W, et al
    Protective Effects of Dietary Supplementation with a Combination of Nutrients in a Transgenic Mouse Model of Alzheimer's Disease.
    PLoS One. 2015;10:e0143135.
    PubMed     Text format     Abstract available


  186. NUNES MA, Schowe NM, Monteiro-Silva KC, Baraldi-Tornisielo T, et al
    Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease.
    PLoS One. 2015;10:e0142267.
    PubMed     Text format     Abstract available


  187. LARSEN ME, Curry L, Mastellos N, Robb C, et al
    Development of the CHARIOT Research Register for the Prevention of Alzheimer's Dementia and Other Late Onset Neurodegenerative Diseases.
    PLoS One. 2015;10:e0141806.
    PubMed     Text format     Abstract available


  188. MASSO A, Sanchez A, Gimenez-Llort L, Lizcano JM, et al
    Secreted and Transmembrane alphaKlotho Isoforms Have Different Spatio-Temporal Profiles in the Brain during Aging and Alzheimer's Disease Progression.
    PLoS One. 2015;10:e0143623.
    PubMed     Text format     Abstract available


  189. KO SY, Ko HA, Chu KH, Shieh TM, et al
    The Possible Mechanism of Advanced Glycation End Products (AGEs) for Alzheimer's Disease.
    PLoS One. 2015;10:e0143345.
    PubMed     Text format     Abstract available


  190. BARBER RC, Phillips NR, Tilson JL, Huebinger RM, et al
    Can Genetic Analysis of Putative Blood Alzheimer's Disease Biomarkers Lead to Identification of Susceptibility Loci?
    PLoS One. 2015;10:e0142360.
    PubMed     Text format     Abstract available


  191. BYUN MS, Kim SE, Park J, Yi D, et al
    Heterogeneity of Regional Brain Atrophy Patterns Associated with Distinct Progression Rates in Alzheimer's Disease.
    PLoS One. 2015;10:e0142756.
    PubMed     Text format     Abstract available


  192. CAO S, Yu L, Mao J, Wang Q, et al
    Uncovering the Molecular Mechanism of Actions between Pharmaceuticals and Proteins on the AD Network.
    PLoS One. 2015;10:e0144387.
    PubMed     Text format     Abstract available


  193. SAPEY-TRIOMPHE LA, Heckemann RA, Boublay N, Dorey JM, et al
    Neuroanatomical Correlates of Recognizing Face Expressions in Mild Stages of Alzheimer's Disease.
    PLoS One. 2015;10:e0143586.
    PubMed     Text format     Abstract available


  194. ZHONG G, Wang Y, Zhang Y, Guo JJ, et al
    Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers.
    PLoS One. 2015;10:e0118333.
    PubMed     Text format     Abstract available


  195. BRENDEL M, Jaworska A, Griessinger E, Rotzer C, et al
    Cross-Sectional Comparison of Small Animal [18F]-Florbetaben Amyloid-PET between Transgenic AD Mouse Models.
    PLoS One. 2015;10:e0116678.
    PubMed     Text format     Abstract available


  196. FUSO A, Ferraguti G, Scarpa S, Ferrer I, et al
    Disclosing bias in bisulfite assay: MethPrimers underestimate high DNA methylation.
    PLoS One. 2015;10:e0118318.
    PubMed     Text format     Abstract available


  197. OKABAYASHI S, Shimozawa N, Yasutomi Y, Yanagisawa K, et al
    Diabetes Mellitus Accelerates Abeta Pathology in Brain Accompanied by Enhanced GAbeta Generation in Nonhuman Primates.
    PLoS One. 2015;10:e0117362.
    PubMed     Text format     Abstract available


  198. WANG X, Blanchard J, Grundke-Iqbal I, Iqbal K, et al
    Memantine Attenuates Alzheimer's Disease-Like Pathology and Cognitive Impairment.
    PLoS One. 2015;10:e0145441.
    PubMed     Text format     Abstract available


  199. DAIANU M, Jacobs RE, Weitz TM, Town TC, et al
    Multi-Shell Hybrid Diffusion Imaging (HYDI) at 7 Tesla in TgF344-AD Transgenic Alzheimer Rats.
    PLoS One. 2015;10:e0145205.
    PubMed     Text format     Abstract available


  200. JIAO B, Liu X, Zhou L, Wang MH, et al
    Polygenic Analysis of Late-Onset Alzheimer's Disease from Mainland China.
    PLoS One. 2015;10:e0144898.
    PubMed     Text format     Abstract available


  201. NUNES MA, Schowe NM, Monteiro-Silva KC, Baraldi-Tornisielo T, et al
    Correction: Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease.
    PLoS One. 2015;10:e0145695.
    PubMed     Text format     Abstract available


  202. WANG S, Cui Y, Wang C, Xie W, et al
    Correction: Protective Effects of Dietary Supplementation with a Combination of Nutrients in a Transgenic Mouse Model of Alzheimer's Disease.
    PLoS One. 2015;10:e0146252.
    PubMed     Text format     Abstract available


  203. SU Y, Blazey TM, Snyder AZ, Raichle ME, et al
    Quantitative amyloid imaging using image-derived arterial input function.
    PLoS One. 2015;10:e0122920.
    PubMed     Text format     Abstract available


  204. TOLEA MI, Morris JC, Galvin JE
    Longitudinal associations between physical and cognitive performance among community-dwelling older adults.
    PLoS One. 2015;10:e0122878.
    PubMed     Text format     Abstract available


  205. MAANI R, Yang YH, Kalra S
    Voxel-based texture analysis of the brain.
    PLoS One. 2015;10:e0117759.
    PubMed     Text format     Abstract available


  206. CAI S, Huang L, Zou J, Jing L, et al
    Changes in thalamic connectivity in the early and late stages of amnestic mild cognitive impairment: a resting-state functional magnetic resonance study from ADNI.
    PLoS One. 2015;10:e0115573.
    PubMed     Text format     Abstract available


  207. SANKARANARAYANAN S, Barten DM, Vana L, Devidze N, et al
    Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models.
    PLoS One. 2015;10:e0125614.
    PubMed     Text format     Abstract available


  208. REDOLFI A, Manset D, Barkhof F, Wahlund LO, et al
    Head-to-head comparison of two popular cortical thickness extraction algorithms: a cross-sectional and longitudinal study.
    PLoS One. 2015;10:e0117692.
    PubMed     Text format     Abstract available


  209. YOSHITA M, Arai H, Arai H, Arai T, et al
    Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study.
    PLoS One. 2015;10:e0120540.
    PubMed     Text format     Abstract available


  210. CAMARGO LM, Zhang XD, Loerch P, Caceres RM, et al
    Pathway-based analysis of genome-wide siRNA screens reveals the regulatory landscape of APP processing.
    PLoS One. 2015;10:e0115369.
    PubMed     Text format     Abstract available


  211. DWORZAK J, Renvoise B, Habchi J, Yates EV, et al
    Neuronal Cx3cr1 Deficiency Protects against Amyloid beta-Induced Neurotoxicity.
    PLoS One. 2015;10:e0127730.
    PubMed     Text format     Abstract available


  212. MORIYA M, Miyajima M, Nakajima M, Ogino I, et al
    Impact of cerebrospinal fluid shunting for idiopathic normal pressure hydrocephalus on the amyloid cascade.
    PLoS One. 2015;10:e0119973.
    PubMed     Text format     Abstract available


  213. LYKHMUS O, Voytenko L, Koval L, Mykhalskiy S, et al
    alpha7 Nicotinic acetylcholine receptor-specific antibody induces inflammation and amyloid beta42 accumulation in the mouse brain to impair memory.
    PLoS One. 2015;10:e0122706.
    PubMed     Text format     Abstract available


  214. JUNG CK, Keppler K, Steinbach S, Blazquez-Llorca L, et al
    Fibrillar amyloid plaque formation precedes microglial activation.
    PLoS One. 2015;10:e0119768.
    PubMed     Text format     Abstract available


  215. XUE M, Zhu L, Zhang J, Qiu J, et al
    Low dose nicotine attenuates Abeta neurotoxicity through activation early growth response gene 1 pathway.
    PLoS One. 2015;10:e0120267.
    PubMed     Text format     Abstract available


  216. WU CY, Hu HY, Chow LH, Chou YJ, et al
    The Effects of Anti-Dementia and Nootropic Treatments on the Mortality of Patients with Dementia: A Population-Based Cohort Study in Taiwan.
    PLoS One. 2015;10:e0130993.
    PubMed     Text format     Abstract available


  217. WOLFF M, Unuchek D, Zhang B, Gordeliy V, et al
    Amyloid beta Oligomeric Species Present in the Lag Phase of Amyloid Formation.
    PLoS One. 2015;10:e0127865.
    PubMed     Text format     Abstract available


  218. CHEN J, Li S, Sun W, Li J, et al
    Anti-Diabetes Drug Pioglitazone Ameliorates Synaptic Defects in AD Transgenic Mice by Inhibiting Cyclin-Dependent Kinase5 Activity.
    PLoS One. 2015;10:e0123864.
    PubMed     Text format     Abstract available


  219. SAVONENKO AV, Melnikova T, Wang Y, Ravert H, et al
    Cannabinoid CB2 Receptors in a Mouse Model of Abeta Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation.
    PLoS One. 2015;10:e0129618.
    PubMed     Text format     Abstract available


  220. CAUGHLIN S, Hepburn JD, Park DH, Jurcic K, et al
    Increased Expression of Simple Ganglioside Species GM2 and GM3 Detected by MALDI Imaging Mass Spectrometry in a Combined Rat Model of Abeta Toxicity and Stroke.
    PLoS One. 2015;10:e0130364.
    PubMed     Text format     Abstract available


    January 2014
  221. ZHENG X, Demirci FY, Barmada MM, Richardson GA, et al
    A Rare Duplication on Chromosome 16p11.2 Is Identified in Patients with Psychosis in Alzheimer's Disease.
    PLoS One. 2014;9:e111462.
    PubMed     Text format     Abstract available


  222. LIN LX, Bo XY, Tan YZ, Sun FX, et al
    Feasibility of beta-Sheet Breaker Peptide-H102 Treatment for Alzheimer's Disease Based on beta-Amyloid Hypothesis.
    PLoS One. 2014;9:e112052.
    PubMed     Text format     Abstract available


  223. KUMAR A, Pate KM, Moss MA, Dean DN, et al
    Self-propagative replication of abeta oligomers suggests potential transmissibility in Alzheimer disease.
    PLoS One. 2014;9:e111492.
    PubMed     Text format     Abstract available


  224. CHANG L, Wang Y, Ji H, Dai D, et al
    Elevation of peripheral BDNF promoter methylation links to the risk of Alzheimer's disease.
    PLoS One. 2014;9:e110773.
    PubMed     Text format     Abstract available


  225. WANG XB, Cui NH, Yang J, Qiu XP, et al
    Angiotensin-converting enzyme insertion/deletion polymorphism is not a major determining factor in the development of sporadic Alzheimer disease: evidence from an updated meta-analysis.
    PLoS One. 2014;9:e111406.
    PubMed     Text format     Abstract available


  226. LI JJ, Dolios G, Wang R, Liao FF, et al
    Soluble beta-amyloid peptides, but not insoluble fibrils, have specific effect on neuronal microRNA expression.
    PLoS One. 2014;9:e90770.
    PubMed     Text format     Abstract available


  227. IZZO NJ, Xu J, Zeng C, Kirk MJ, et al
    Alzheimer's Therapeutics Targeting Amyloid Beta 1-42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity.
    PLoS One. 2014;9:e111899.
    PubMed     Text format     Abstract available


  228. IZZO NJ, Staniszewski A, To L, Fa M, et al
    Alzheimer's Therapeutics Targeting Amyloid Beta 1-42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits.
    PLoS One. 2014;9:e111898.
    PubMed     Text format     Abstract available


  229. HSU YH, Huang CF, Tu MC, Hua MS, et al
    The clinical utility of informants' appraisals on prospective and retrospective memory in patients with early Alzheimer's disease.
    PLoS One. 2014;9:e112210.
    PubMed     Text format     Abstract available


  230. ANSTEY KJ, Cherbuin N, Herath PM, Qiu C, et al
    A self-report risk index to predict occurrence of dementia in three independent cohorts of older adults: the ANU-ADRI.
    PLoS One. 2014;9:e86141.
    PubMed     Text format     Abstract available


  231. BURKE JF, Langa KM, Hayward RA, Albin RL, et al
    Modeling Test and Treatment Strategies for Presymptomatic Alzheimer Disease.
    PLoS One. 2014;9:e114339.
    PubMed     Text format     Abstract available


  232. LI S, Wei Z, Chen J, Chen Y, et al
    Oral Administration of a Fusion Protein between the Cholera Toxin B Subunit and the 42-Amino Acid Isoform of Amyloid-beta Peptide Produced in Silkworm Pupae Protects against Alzheimer's Disease in Mice.
    PLoS One. 2014;9:e113585.
    PubMed     Text format     Abstract available


  233. LEE SJ, Ritchie CS, Yaffe K, Stijacic Cenzer I, et al
    A clinical index to predict progression from mild cognitive impairment to dementia due to Alzheimer's disease.
    PLoS One. 2014;9:e113535.
    PubMed     Text format     Abstract available


  234. LIU Y, Yu JT, Wang HF, Hao XK, et al
    Association between NME8 Locus Polymorphism and Cognitive Decline, Cerebrospinal Fluid and Neuroimaging Biomarkers in Alzheimer's Disease.
    PLoS One. 2014;9:e114777.
    PubMed     Text format     Abstract available


  235. CHEN P, Wang L, Wang Y, Li S, et al
    Phosphoproteomic profiling of selenate-treated Alzheimer's disease model cells.
    PLoS One. 2014;9:e113307.
    PubMed     Text format     Abstract available


  236. JIMENEZ S, Navarro V, Moyano J, Sanchez-Mico M, et al
    Disruption of amyloid plaques integrity affects the soluble oligomers content from Alzheimer disease brains.
    PLoS One. 2014;9:e114041.
    PubMed     Text format     Abstract available


  237. NOBLE JM, Scarmeas N, Celenti RS, Elkind MS, et al
    Serum IgG Antibody Levels to Periodontal Microbiota Are Associated with Incident Alzheimer Disease.
    PLoS One. 2014;9:e114959.
    PubMed     Text format     Abstract available


  238. MAURIN H, Chong SA, Kraev I, Davies H, et al
    Early structural and functional defects in synapses and myelinated axons in stratum lacunosum moleculare in two preclinical models for tauopathy.
    PLoS One. 2014;9:e87605.
    PubMed     Text format     Abstract available



  239. Correction: age-dependent modulation of synaptic plasticity and insulin mimetic effect of lipoic Acid on a mouse model of Alzheimer's disease.
    PLoS One. 2014;9:e116442.
    PubMed     Text format     Abstract available


  240. DOBROWOLSKA JA, Kasten T, Huang Y, Benzinger TL, et al
    Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system.
    PLoS One. 2014;9:e89998.
    PubMed     Text format     Abstract available


  241. ORTIZ A, Gorriz JM, Ramirez J, Martinez-Murcia FJ, et al
    Automatic ROI selection in structural brain MRI using SOM 3D projection.
    PLoS One. 2014;9:e93851.
    PubMed     Text format     Abstract available


  242. LIU X, Zhou J, Abid MD, Yan H, et al
    Berberine attenuates axonal transport impairment and axonopathy induced by Calyculin A in N2a cells.
    PLoS One. 2014;9:e93974.
    PubMed     Text format     Abstract available


  243. MANNING EN, Barnes J, Cash DM, Bartlett JW, et al
    APOE epsilon4 is associated with disproportionate progressive hippocampal atrophy in AD.
    PLoS One. 2014;9:e97608.
    PubMed     Text format     Abstract available


  244. KWAK JW, Jeong H, Han SH, Kim Y, et al
    Phosphokinase antibody arrays on dendron-coated surface.
    PLoS One. 2014;9:e96456.
    PubMed     Text format     Abstract available


  245. PYYKKO OT, Lumela M, Rummukainen J, Nerg O, et al
    Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus.
    PLoS One. 2014;9:e91974.
    PubMed     Text format     Abstract available


  246. YU G, Liu Y, Thung KH, Shen D, et al
    Multi-task linear programming discriminant analysis for the identification of progressive MCI individuals.
    PLoS One. 2014;9:e96458.
    PubMed     Text format     Abstract available


  247. ZHOU R, Xu B
    Insight of the cytotoxicity of the aggregates of peptides or aberrant proteins: a meta-analysis.
    PLoS One. 2014;9:e95759.
    PubMed     Text format     Abstract available


  248. SATOH M, Ogawa J, Tokita T, Nakaguchi N, et al
    The effects of physical exercise with music on cognitive function of elderly people: Mihama-Kiho project.
    PLoS One. 2014;9:e95230.
    PubMed     Text format     Abstract available


  249. VARGAS LM, Leal N, Estrada LD, Gonzalez A, et al
    EphA4 activation of c-Abl mediates synaptic loss and LTP blockade caused by amyloid-beta oligomers.
    PLoS One. 2014;9:e92309.
    PubMed     Text format     Abstract available


  250. FARRAR CT, William CM, Hudry E, Hashimoto T, et al
    RNA aptamer probes as optical imaging agents for the detection of amyloid plaques.
    PLoS One. 2014;9:e89901.
    PubMed     Text format     Abstract available


  251. WANG X, Wang H, Li H, Li T, et al
    Frequency of the apolipoprotein E epsilon4 allele in a memory clinic cohort in Beijing: a naturalistic descriptive study.
    PLoS One. 2014;9:e99130.
    PubMed     Text format     Abstract available


  252. LAITERA T, Sarajarvi T, Haapasalo A, Puli L, et al
    Increased gamma-secretase activity in idiopathic normal pressure hydrocephalus patients with beta-amyloid pathology.
    PLoS One. 2014;9:e93717.
    PubMed     Text format     Abstract available


  253. GAO J, Cheung RT, Chan YS, Chu LW, et al
    The relevance of short-range fibers to cognitive efficiency and brain activation in aging and dementia.
    PLoS One. 2014;9:e90307.
    PubMed     Text format     Abstract available


  254. BEAUCHET O, Launay CP, Merjagnan C, Kabeshova A, et al
    Quantified self and comprehensive geriatric assessment: older adults are able to evaluate their own health and functional status.
    PLoS One. 2014;9:e100636.
    PubMed     Text format     Abstract available


  255. XU Z, Shen X, Pan W
    Longitudinal analysis is more powerful than cross-sectional analysis in detecting genetic association with neuroimaging phenotypes.
    PLoS One. 2014;9:e102312.
    PubMed     Text format     Abstract available


  256. LI R, Perneczky R, Yakushev I, Forster S, et al
    Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer's Disease.
    PLoS One. 2015;10:e0122731.
    PubMed     Text format     Abstract available


  257. NERY LR, Eltz NS, Hackman C, Fonseca R, et al
    Brain intraventricular injection of amyloid-beta in zebrafish embryo impairs cognition and increases tau phosphorylation, effects reversed by lithium.
    PLoS One. 2014;9:e105862.
    PubMed     Text format     Abstract available


  258. GREINER ER, Kelly JW, Palhano FL
    Immunoprecipitation of amyloid fibrils by the use of an antibody that recognizes a generic epitope common to amyloid fibrils.
    PLoS One. 2014;9:e105433.
    PubMed     Text format     Abstract available


  259. JOSE JC, Chatterjee P, Sengupta N
    Cross dimerization of amyloid-beta and alphasynuclein proteins in aqueous environment: a molecular dynamics simulations study.
    PLoS One. 2014;9:e106883.
    PubMed     Text format     Abstract available


  260. SHANG D, Li C, Yao Q, Yang H, et al
    Prioritizing candidate disease metabolites based on global functional relationships between metabolites in the context of metabolic pathways.
    PLoS One. 2014;9:e104934.
    PubMed     Text format     Abstract available


  261. HETTICH MM, Matthes F, Ryan DP, Griesche N, et al
    The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex.
    PLoS One. 2014;9:e102420.
    PubMed     Text format     Abstract available


  262. PETERSON J, Gisslen M, Zetterberg H, Fuchs D, et al
    Cerebrospinal Fluid (CSF) Neuronal Biomarkers across the Spectrum of HIV Infection: Hierarchy of Injury and Detection.
    PLoS One. 2014;9:e116081.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: